SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-13-352299
Filing Date
2013-08-29
Accepted
2013-08-29 17:13:39
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d585873ds1.htm S-1 1855594
2 EX-23.1 d585873dex231.htm EX-23.1 1682
3 EX-23.2 d585873dex232.htm EX-23.2 3133
10 GRAPHIC g585873001.jpg GRAPHIC 24257
11 GRAPHIC g585873wblogoc.jpg GRAPHIC 2751
  Complete submission text file 0001193125-13-352299.txt   11001490

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lpcn-20130630.xml EX-101.INS 1191430
5 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20130630.xsd EX-101.SCH 47397
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20130630_cal.xml EX-101.CAL 58921
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20130630_def.xml EX-101.DEF 300232
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20130630_lab.xml EX-101.LAB 381765
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20130630_pre.xml EX-101.PRE 355027
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-190897 | Film No.: 131069996
SIC: 2834 Pharmaceutical Preparations